부산대학교 도서관

Gorovits B; Regeneron Pharmaceuticals, Inc, Tarrytown, USA. boris.gorovits@regeneron.com.; Azadeh M; Progeria Research Foundation, Inc., Cambridge, Massachusetts, USA.; Fiscella M; REGENXBIO Inc, Rockville, USA.; Harrison T; Precision for Medicine Inc., Frederick, Maryland, USA.; Hofer M; Jefferson Institute for Bioprocessing, Lower Gwynedd, USA.; Janetzki S; ZellNet Consulting, Inc, Fort Lee, New Jersey, USA.; Jawa V; EpiVax, Inc, Providence, Rhode Island, USA.; Long B; 4D Molecular Therapeutics, Emeryville, USA.; Lu Y; Sangamo Therapeutics, Inc, Richmond, USA.; Mahnke YD; FlowKnowHow LLC, New York, USA.; Maia M; South San Francisco, CA, USA.; Majumdar R; LabCorp Holdings, Inc, Burlington, USA.; Miller M; Miller Bioanalytical Consulting LLC, Carlsbad, USA.; Milton M; Lake Boon Pharmaceutical Consulting, LLC, Hudson, USA.; Nelson R; BioAgilytix Labs, LLC, Durham, USA.; Partridge MA; Regeneron Pharmaceuticals, Inc, Tarrytown, USA.; Shaik S; Takeda Pharmaceutical Company Limited, Cambridge, USA.; Snoeck V; UCB, B-1420, Braine-l'Alleud, Belgium.; Vettermann C; 4D Molecular Therapeutics, Emeryville, USA.; Wu B; Johnson & Johnson Innovative Medicine, Titusville, USA.; Zhao A; Regeneron Pharmaceuticals, Inc, Tarrytown, USA.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Britten, CM; Janetzki, S; Ben-Porat, L; Clay, TM; Kalos, M; Maecker, H; Odunsi, K; Pride, M; Old, L; Hoos, A

CANCER IMMUNOLOGY IMMUNOTHERAPY. 58(10):1701-1713

Wallace PK; ISAC Educator in Chief, Washington, DC, USA.; SciGro, Inc., Sedona, Arizona, USA.; Jellison ER; University of Connecticut School of Medicine, Farmington, Connecticut, USA.; Thornton S; Department of Pediatrics, University of Cincinnati College of Medicine; Division of Rheumatology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Kluepfel K; Moderna Therapeutics, Cambridge, Massachusetts, USA.; Back J; Wayne State University School of Medicine, Detroit, Michigan, USA.; Beadnell TC; Eurofins Clinical Trial Solutions, Lenexa, Kansas, USA.; Bebes A; Centre for Cytomics, University of Exeter, Exeter, UK.; Behrends J; Core Facility Fluorescence Cytometry, Research Center Borstel, Leibniz Lung Center, Borstel, Schleswig-Holstein, Germany.; Belkina AC; Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts, USA.; Black M; Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Bogdanoski G; Bristol Myers Squibb, Princeton, New Jersey, USA.; Bollati-Fogolín M; Institut Pasteur de Montevideo, Montevideo, Uruguay.; Bonte S; Ghent University and VIB-UGent Center for Inflammation Research, Ghent, Belgium.; Van der Borght K; VIB-Ghent University, Ghent, Belgium.; Brinkman RR; Dotmatics, Boston, Massachusetts, USA.; University of British Columbia, Vancouver, British Columbia, Canada.; Brundage K; West Virginia University (WVU) Flow Cytometry & Single Cell Core Facility, Morgantown, West Virginia, USA.; Bushnell T; University of Rochester, Rochester, New York, USA.; Chiu DT; University of Washington, Seattle, Washington, USA.; Chow N; BC Cancer Research Centre, Vancouver, British Columbia, Canada.; Ciccolella CO; Dotmatics, Boston, Massachusetts, USA.; Cochran M; University of Rochester, Rochester, New York, USA.; Czechowska K; Metafora Biosystems, Paris, France.; Dagla K; Babraham Institute, Cambridge, UK.; Daniel B; Regeneron Pharmaceuticals, Tarrytown, New York, USA.; de la Cruz G; Flow Cytometry Platform, NNF Center for Stem Cell Medicine - reNEW, Dept of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark.; Van Duyse J; VIB-Ghent University, Ghent, Belgium.; Font LF; Scientific Affairs, R&D, BD Biosciences, San José, California, USA.; Fornas Ò; Centre for Genomic Regulation (CRG), Pompeu Fabra University (UPF), Barcelona, Spain.; Garcia-Garcia S; Department of Molecular Cell Biology and Immunology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; Gardner R; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Van Gassen S; VIB-Ghent University, Ghent, Belgium.; Gimenes D; Flow Cytometry Core Facility, European Molecular Biology Laboratory (EMBL), Heidelberg, Baden-Württemberg, Germany.; Grenfell R; Cancer Research UK (CRUK) Cambridge Institute, Cambridge, UK.; Grider-Hayes MJ; University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Grose R; South Australian Health and Medical Research Institute (SAHMRI), Adelaide, South Australia, Australia.; Hall C; Babraham Institute, Cambridge, UK.; Hally KE; University of Otago, Wellington (Ōtākou Whakaihu Waka ki Pōneke), Wellington, New Zealand.; Hameetman M; Leiden University Medical Center (LUMC), Leiden, the Netherlands.; Hogg K; Bioscience Technology Facility, University of York, York, UK.; Houston J; New Mexico State University, Las Cruces, New Mexico, USA.; Irish JM; University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; Isterdael GV; VIB Flow Core, VIB Center for Inflammation Research, Ghent, Belgium.; Jaimes M; Cytek Biosciences, Inc., Fremont, California, USA.; Janetzki S; ZellNet Consulting, Inc., Fort Lee, New Jersey, USA.; Kim C; La Jolla Institute for Immunology, San Diego, California, USA.; Koladiya A; Division of Hematology, Oncology, and Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA.; ISAC Chair of Data Committee, Washington, DC, USA.; Lamote J; VIB Flow Core, VIB Technologies, and VIB Center for Cancer Biology, Department of Oncology, University of Leuven, Leuven, Belgium.; Lannigan J; Flow Cytometry Support Services, LLC, Alexandria, Virginia, USA.; Leconte J; McGill University, Montréal, Canada.; Litwin V; Eurofins Clinical Trial Solutions, Bromont, Quebec, Canada.; Longhini A; Sony Biotechnology Inc, San Jose, California, USA.; Loof N; BD Biosciences Life Sciences, Ashland, Oregon, USA.; Lozano-Andrés E; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.; Lundsten K; Luminous Bioanalytical Consulting, Fort Collins, Colorado, USA.; Mage P; BD Biosciences, San Jose, California, USA.; Mair F; Flow Cytometry Core Facility, ETH Zurich, Zurich, Switzerland.; Martins CG; Comprehensive Health Research Centre (CHRC), NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade NOVA de Lisboa, Lisboa, Portugal.; McCausland M; IQVIA Laboratories, Marietta, Georgia, USA.; McGuire HM; The University of Sydney, Sydney, New South Wales, Australia.; Meskas J; Dotmatics, Boston, Massachusetts, USA.; Murphy W; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Nolan J; Scintillon Institute, San Diego, California, USA.; Oliveira B; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Ordoñez-Rueda D; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Orlowski-Oliver E; Peter MacCallum Cancer Center, Melbourne, Australia.; Petersen CC; Aarhus University, Aarhus, Denmark.; Poulton NJ; Center for Aquatic Cytometry, Bigelow Laboratory for Ocean Sciences, East Boothbay, Maine, USA.; Putri G; The Walter and Eliza Hall Institute of Medical Research, and Department of Medical Biology, University of Melbourne, Parkville, Victoria, Australia.; Quadrini KJ; Prothena Biosciences Inc, Brisbane, California, USA.; Ramasz B; Flow Cytometry Core Facility, European Molecular Biology Laboratory (EMBL), Heidelberg, Baden-Württemberg, Germany.; Ruhrmund D; BioMarin Pharmaceuticals, Novato, California, USA.; Singh VV; Eurofins Clinical Trial Solutions, Lenexa, Kansas, USA.; Small SJ; Malaghan Institute of Medical Research, Wellington, New Zealand.; Smith NJ; The University of Sydney, Sydney, New South Wales, Australia.; Spidlen J; BD Biosciences Life Sciences, Ashland, Oregon, USA.; Stegen C; McGill University, Montréal, Canada.; Tak T; Leiden University Medical Center (LUMC), Leiden, the Netherlands.; Thompson S; Babraham Institute, Cambridge, UK.; Thomson M; Hudson Institute of Medical Research, Melbourne, Australia.; Vocelle D; St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Walker RV; Babraham Institute, Cambridge, UK.; Walsh RE; Eli Lilly and Company, Indianapolis, Indiana, USA.; Wang L; National Institute of Standards and Technology (NIST), Gaithersburg, Maryland, USA.; Wang YF; AHEAD Medicine Corporation, San Jose, California, USA.; Weglarz M; University of Texas Medical Branch (UTMB), Galveston, Texas, USA.; Winker M; Flow Cytometry Core Facility, European Molecular Biology Laboratory (EMBL), Heidelberg, Baden-Württemberg, Germany.; Wood JCS; Cytometry & Biophotonics Consultant, Galax, Virginia, USA.; Woolard S; St. Jude Children's Research Hospital, Memphis, Tennessee, USA.; Yeh NY; AHEAD Medicine Corporation, San Jose, California, USA.; Yuecel R; Centre for Cytomics, University of Exeter, Exeter, UK.; Rajwa B; ISAC, Editor in Chief, Washington, DC, USA.; Purdue University, West Lafayette, Indiana, USA.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 101235694 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4930 (Electronic) Linking ISSN: 15524922 NLM ISO Abbreviation: Cytometry A Subsets: MEDLINE

Rachel Milte; Renly Lim; Peter Brown; Joseph Whitehouse; Helen Stone; Elizabeth E Roughead; Eyob Alemayehu Gebreyohannes; Dorothea Dumuid; Monique S Boord; Julian Soriano; Tahlia Meola; Nigel H Lovell; Jack L Janetzki

BMJ Open, Vol 14, Iss 2 (2024)

Kathryn S. Patton; M. Travis Harrison; Brian R. Long; Kelly Lau; Jennifer Holcomb; Rachel Owen; Theresa Kasprzyk; Sylvia Janetzki; Stephen J. Zoog; Christian Vettermann

Molecular Therapy: Methods & Clinical Development, Vol 22, Iss , Pp 183-195 (2021)

Bui, Tien Ngoc Thi; Au, Ruby Tszwai; Janetzki, Jack Luke; McMillan, Sara S.; Hotham, Elizabeth; Suppiah, Vijayaprakash

ADMINISTRATION AND POLICY IN MENTAL HEALTH AND MENTAL HEALTH SERVICES RESEARCH; AUG 17 2024, 29p.

Butterfield, L.H.; Palucka, A.K.; Britten, C.M.; Dhodapkar, M.V.; Hakansson, L.; Janetzki, S.; Kawakami, Y.; Kleen, T.O.; Lee, P.P.; Maccalli, C.; Maecker, H.T.; Maino, V.C.; Maio, M.; Malyguine, A.; Masucci, G.; Pawelec, G.; Potter, D.M.; Rivoltini, L.; Salazar, L.G.; Schendel, D.J.; Slingluff, C.L.; Song, W.R.; Stroncek, D.F.; Tahara, H.; Thurin, M.; Trinchieri, G.; Burg, S.H. van der; Whiteside, T.L.; Wigginton, J.M.; Marincola, F.; Khleif, S.; Fox, B.A.; Disis, M.L.

Clinical Cancer Research. 17:3064-3076

Janetzki, S.; Price, L.; Schroeder, H.; Britten, C.M.; Welters, M.J.P.; Hoos, A.

Nature Protocols. 10:1098-1115

Janetzki, S.; Panageas, K.S.; Ben-Porat, L.; Boyer, J.; Britten, C.M.; Clay, T.M.; Kalos, M.; Maecker, H.T.; Romero, P.; Yuan, J.; Kast, W.M.; Hoos, A.

Cancer Immunol Immunother
Cancer Immunology, Immunotherapy, vol. 57, no. 3, pp. 303-315

Filbert, H.; Attig, S.; Bidmon, N.; Renard, B.Y.; Janetzki, S.; Sahin, U.; Welters, M.J.P.; Ottensmeier, C.; Burg, S.H. van der; Gouttefangeas, C.; Britten, C.M.

Cancer Immunol Immunother

Britten, C. M.; Janetzki, S.; Burg, S. H.; Gouttefangeas, C.; Hoos, A.

Cancer Immunology, Immunotherapy. March, 2008, Vol. 57 Issue 3, p285, 4 p.

Britten, C. M.; Janetzki, S.; van der Burg, S. H.; Gouttefangeas, C.; Hoos, A.

Cancer Immunol Immunother

Gorovits B; Sana Biotechnology, Cambridge, Massachusetts, USA. boris.gorovits@sana.com.; Azadeh M; Ultragenyx Pharmaceutical Inc, Novato, California, USA.; Buchlis G; University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Fiscella M; Regenxbio Inc, Rockville, Maryland, USA.; Harrison T; Precision for Medicine, Inc, Redwood City, California, USA.; Havert M; Gene Therapy Partners, San Diego, California, USA.; Janetzki S; ZellNet Consulting, Inc, Fort Lee, New Jersey, USA.; Jawa V; Bristol Myers Squibb Pharmaceutical, Princeton, New Jersey, USA.; Long B; BioMarin Pharmaceutical Inc, Novato, California, USA.; Mahnke YD; FlowKnowHow LLC, Brooklyn, New York, USA.; McDermott A; Labcorp Early Development Laboratories Inc, Indianapolis, Indiana, USA.; Milton M; Lake Boon Pharmaceutical Consulting LLC, Hudson, New York, USA.; Nelson R; BioAgilytix Europe GmbH, Hamburg, Germany.; Vettermann C; BioMarin Pharmaceutical Inc, Novato, California, USA.; Wu B; Janssen Pharmaceuticals, Raritan, New Jersey, USA.

Publisher: American Association of Pharmaceutical Scientists Country of Publication: United States NLM ID: 101223209 Publication Model: Electronic Cited Medium: Internet ISSN: 1550-7416 (Electronic) Linking ISSN: 15507416 NLM ISO Abbreviation: AAPS J Subsets: MEDLINE

Hoos, A; Eggermont, Lex; Janetzki, S; Hodi, FS; Ibrahim, R (Ramy); Anderson, A; Humphrey, R; Blumenstein, B; Old, L; Wolchok, J

J Natl Cancer Inst

Moodie, Z.; Price, L.; Gouttefangeas, C.; Mander, A.; Janetzki, S.; Lower, M.; Welters, M.J.P.; Ottensmeier, C.; Burg, S.H. van der; Britten, C.M.

Cancer Immunol Immunother

Janetzki, S.; Price, L.; Britten, C.M.; Burg, S.H. van der; Caterini, J.; Currier, J.R.; Ferrari, G.; Gouttefangeas, C.; Hayes, P.; Kaempgen, E.; Lennerz, V.; Nihlmark, K.; Souza, V.; Hoos, A.

Cancer Immunol Immunother

Berrong M; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.; Ferrari G; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Duke Center for AIDS Research, Duke University Medical Center, Durham, NC 27710, USA.; Porth C; Duke Research and Discovery, Research Triangle Park, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, 27710, NC, USA.; Davis D; Seraworx, PO Box 202, Providence, UT 84332, USA.; Denny T; Duke Research and Discovery, Research Triangle Park, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, 27710, NC, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.; Janetzki S; ZellNet Consulting, Inc., 555 North Ave, Suite 25-S, Fort Lee, NJ 07024, USA.; Rountree W; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Duke Research and Discovery, Research Triangle Park, Durham, NC 27710, USA. Electronic address: wes.rountree@duke.edu.

Publisher: Elsevier Country of Publication: Netherlands NLM ID: 1305440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7905 (Electronic) Linking ISSN: 00221759 NLM ISO Abbreviation: J Immunol Methods Subsets: MEDLINE

Britten, C. M.; Janetzki, S.; van der Burg, S. H.; Huber, C.; Kalos, M.; Levitsky, H. I.; Maecker, H. T.; Melief, C. J. M.; O’Donnell-Tormey, J.; Odunsi, K.; Old, L. J.; Pawelec, G.; Roep, B. O.; Romero, P.; Hoos, A.; Davis, M. M.

Cancer Immunology, Immunotherapy. January 2011 60(1):15-22

Dobbin, KK; Cesano, A; Alvarez, J; Hawtin, R; Janetzki, S; Kirsch, I; Masucci, GV; Robbins, PB; Selvan, SR; Streicher, HZ

JOURNAL FOR IMMUNOTHERAPY OF CANCER. 4

Hosseini Z; Translational Science and Innovation Laboratory (TSAIL), Q Solutions, Durham, NC, USA.; Groves CJ; Translational Science and Innovation Laboratory (TSAIL), Q Solutions, Durham, NC, USA.; Anders P; Translational Science and Innovation Laboratory (TSAIL), Q Solutions, Durham, NC, USA.; Cave K; Translational Science and Innovation Laboratory (TSAIL), Q Solutions, Durham, NC, USA.; Krunkosky M; Translational Science and Innovation Laboratory (TSAIL), Q Solutions, Durham, NC, USA.; Chappell B; Translational Science and Innovation Laboratory (TSAIL), Q Solutions, Durham, NC, USA.; Pattyn S; ImmunXperts, a Q Solutions Company, Gosselies, Belgium.; Davis D; Seraworx, Providence, UT, USA.; Janetzki S; ZellNet Consulting, Inc., Fort Lee, NJ, USA.; Reap E; Translational Science and Innovation Laboratory (TSAIL), Q Solutions, Durham, NC, USA. Elizabeth.Reap@q2labsolutions.com.

Publisher: Humana Press Country of Publication: United States NLM ID: 9214969 Publication Model: Print Cited Medium: Internet ISSN: 1940-6029 (Electronic) Linking ISSN: 10643745 NLM ISO Abbreviation: Methods Mol Biol Subsets: MEDLINE